Pages that link to "Q53335020"
Jump to navigation
Jump to search
The following pages link to Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. (Q53335020):
Displaying 50 items.
- Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline (Q22242395) (← links)
- Cholinesterase inhibitors for dementia with Lewy bodies (Q24248036) (← links)
- Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease (Q26750515) (← links)
- Dementia with Lewy bodies. (Q30586107) (← links)
- Magnetic resonance spectroscopy in common dementias (Q30660402) (← links)
- Differential diagnosis of neurodegenerative diseases using structural MRI data (Q31082974) (← links)
- A genome-wide association study for late-onset Alzheimer's disease using DNA pooling (Q33372576) (← links)
- Incidence and prediction of falls in dementia: a prospective study in older people (Q33444673) (← links)
- Proton magnetic resonance spectroscopy in dementias and mild cognitive impairment (Q33462288) (← links)
- Structural grey matter changes in the substantia innominata in Alzheimer's disease and dementia with Lewy bodies: a DARTEL-VBM study (Q33697892) (← links)
- Diagnosing dementia with Lewy bodies (Q33751527) (← links)
- Vascular risk factors and Alzheimer's disease (Q33808042) (← links)
- Association between APOE epsilon4 allele and vascular dementia: The Cache County study (Q33832935) (← links)
- Donepezil: a review of its use in Alzheimer's disease (Q33914241) (← links)
- Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications (Q33968419) (← links)
- Diagnostic accuracy of the RBANS in mild cognitive impairment: limitations on assessing milder impairments (Q33997698) (← links)
- Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. (Q34079598) (← links)
- Vascular dementia, a new beginning: shifting focus from clinical phenotype to ischemic brain injury (Q34079614) (← links)
- Neuropsychiatric aspects of dementia with Lewy bodies (Q34108197) (← links)
- The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease (Q34138207) (← links)
- Is dementia with Lewy bodies the second most common cause of dementia? (Q34165716) (← links)
- Diagnosis, classification and natural history of degenerative dementias (Q34174197) (← links)
- An overview of common non-Alzheimer dementias (Q34262778) (← links)
- Methodological issues and therapeutic perspectives in vascular dementia: a review (Q34312630) (← links)
- Presenile dementia syndromes: an update on taxonomy and diagnosis (Q34649249) (← links)
- Familial occurrence of dementia with Lewy bodies (Q34696623) (← links)
- Mixed dementia: epidemiology, diagnosis, and treatment (Q34775417) (← links)
- Atypical antipsychotics in Parkinson-sensitive populations (Q34851726) (← links)
- Dementia with Lewy bodies: clinical characteristics and diagnostic criteria. (Q35029466) (← links)
- Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies (Q35183572) (← links)
- Is the distinction between Alzheimer's disease and vascular dementia possible and relevant? (Q35236550) (← links)
- White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging (Q35451667) (← links)
- Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand (Q35468295) (← links)
- Visual association test to detect early dementia of the Alzheimer type (Q35468591) (← links)
- Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease. (Q35468938) (← links)
- Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older (Q35474145) (← links)
- Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation (Q35487636) (← links)
- Cognitive aging and Alzheimer's disease (Q35522121) (← links)
- Hypertension, hypertension-clustering factors and Alzheimer's disease (Q35540392) (← links)
- Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia (Q35553096) (← links)
- Dementia with Lewy bodies. Review of diagnosis and pharmacologic management (Q35573865) (← links)
- Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial (Q35671005) (← links)
- Quantitative magnetic resonance imaging differences between Alzheimer disease with and without subcortical lacunes (Q35677147) (← links)
- Imaging Alzheimer's disease: clinical applications (Q35692950) (← links)
- Evolution of the diagnostic criteria for degenerative and cognitive disorders. (Q35708394) (← links)
- Diagnosis of dementia with Lewy bodies: diagnostic performance of combined ¹²³I-IMP brain perfusion SPECT and ¹²³I-MIBG myocardial scintigraphy (Q35789236) (← links)
- Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype (Q35843937) (← links)
- Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study (Q35899470) (← links)
- Case report of Lewy body disease mimicking Creutzfeldt-Jakob disease in a 44-year-old man (Q36090731) (← links)
- Higher cortical deficits influence attentional processing in dementia with Lewy bodies, relative to patients with dementia of the Alzheimer's type and controls (Q36142447) (← links)